Sponsored by:
CASE CONFERENCE
7/15/11
1:30 p.m. – 2:30 p.m.
5 Maloney Conference Room
Christine Martin, M.D.
HUP
Target Audience
This program has been designed for physicians, fellows and students in the division of Hematology/Oncology.
Educational Objectives
After completing this activity, participants should be able to:

Comprise an appropriate treatment plan for hematologic disorders

Identify new hematology patients

Describe treatment of hematologic disorders

Improve interpretation of bone marrow morphology

Explain pathophysiology of hematologic disorders
Accreditation
The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The University of Pennsylvania School of Medicine designates this educational activity for a maximum of 1 AMA PRA
Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Alexa Davis
215-662-3681 alexa.davis@uphs.upenn.edu

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the University of Pennsylvania School of Medicine for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the University of Pennsylvania School of Medicine and the peer reviewer(s) Zalman
Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
F ACULTY N AME
Alison Loren, MD, MSCE
P RESENTER N AME
Christine Martin, M.D.
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
F ACULTY N AME N AME OF C OMMERCIAL I NTEREST R ELATIONSHIP
Charles Abrams, MD
P RESENTER N AME
GlaxoSmith Kline Former Consultant
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
D ISCLOSURE OF U NAPPROVED U SES OF P RODUCTS
P RESENTER NAME P RODUCT I NVESTIGATIONAL AND / OR O FF LABEL U SE